The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

From migraine to Parkinson’s and obesity, AbbVie is building dominant franchises across multiple high-growth areas. Read why ...

Over the past five years, licensing deals in the U.S. have averaged $84.8 billion. In China? Just $31.3 billion. Even with ...